Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Sep;29(3):995–998. doi: 10.1128/iai.29.3.995-998.1980

Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis.

M P Langford, M Yin-Murphy, Y M Ho, J C Barber, S Baron, G J Stanton
PMCID: PMC551229  PMID: 6159329

Abstract

We report the levels of coxsackievirus type A24 (CA24) and the levels and type of interferon produced early during naturally acquired picornavirus epidemic conjunctivitis. Virus levels ranging from 10(1.8) to 10(5.8) 50% tissue culture infective doses per ml were detected in 29 of 37 acute (collected 1 to 4 days after onset of conjunctivitis) tear samples. Interferon (10(1.5) to 10(3.3) U/ml) was detected in 12 of 29 tear samples collected on day 1, in 2 of 6 tear samples collected on day 2, and in 1 tear sample collected on day 3 after onset of conjunctivitis. The interferon activity in pooled tear samples was completely neutralized by antiserum against human fibroblast interferon, stable at pH 2.0, and active against different viruses. In addition, the interferon activity in tears, like human fibroblast and leukocyte interferons produced in vitro, protected human and rabbit, but not mouse, cells. This is the first report of production and identification of the antigenic type of interferon induced by an enterovirus during natural infection. The early appearance of fibroblast interferon suggests that it may be an important host defense at the local site of implantation against this and possibly other enterovirus infections.

Full text

PDF
995

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blalock J. E., Langford M. P., Georgiades J., Stanton G. J. Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells. Cell Immunol. 1979 Mar 1;43(1):197–201. doi: 10.1016/0008-8749(79)90163-1. [DOI] [PubMed] [Google Scholar]
  2. Blalock J. E., Stanton G. J. Efficient transfer of interferon-induced virus resistance between human cells. J Gen Virol. 1978 Nov;41(2):325–331. doi: 10.1099/0022-1317-41-2-325. [DOI] [PubMed] [Google Scholar]
  3. De Clercq E. Interferon induction by polynucleotides: structure-function relationship. Tex Rep Biol Med. 1977;35:29–38. [PubMed] [Google Scholar]
  4. Degre M., Dahl H. Production of an interferon-like agent following inoculation with bacterial vaccine. Proc Soc Exp Biol Med. 1971 May;137(1):233–236. doi: 10.3181/00379727-137-35551. [DOI] [PubMed] [Google Scholar]
  5. Degré M., Dahl H., Vandvik B. Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders. Acta Neurol Scand. 1976 Feb;53(2):152–160. doi: 10.1111/j.1600-0404.1976.tb04333.x. [DOI] [PubMed] [Google Scholar]
  6. Desmyter J., Rawls W. E., Melnick J. L., Yow M. D., Barrett F. F. Interferon in congenital rubella: response to live attenuated measles vaccine. J Immunol. 1967 Oct;99(4):771–777. [PubMed] [Google Scholar]
  7. Dianzani F., Viano I., Santiano M., Zucca M., Baron S. Effect of cell density of development of the antiviral state in interferon-producing cells: a possible model of in vivo conditions. Proc Soc Exp Biol Med. 1977 Jul;155(3):445–448. doi: 10.3181/00379727-155-39826. [DOI] [PubMed] [Google Scholar]
  8. Epstein L. B., Kreth H. W., Herzenberg L. A. Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol. 1974 Jun;12(3):407–421. doi: 10.1016/0008-8749(74)90097-5. [DOI] [PubMed] [Google Scholar]
  9. GRESSER I., NAFICY K. RECOVERY OF AN INTERFERON-LIKE SUBSTANCE FROM CEREBROSPINAL FLUID. Proc Soc Exp Biol Med. 1964 Oct;117:285–289. doi: 10.3181/00379727-117-29559. [DOI] [PubMed] [Google Scholar]
  10. Green J. A., Stanton G. J., Goode J., Baron S. Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque. J Clin Microbiol. 1976 Dec;4(6):479–485. doi: 10.1128/jcm.4.6.479-485.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hooks J. J., Moutsopoulos H. M., Geis S. A., Stahl N. I., Decker J. L., Notkins A. L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979 Jul 5;301(1):5–8. doi: 10.1056/NEJM197907053010102. [DOI] [PubMed] [Google Scholar]
  12. Kono R. Apollo 11 disease or acute hemorrhagic conjunctivitis: a pandemic of a new enterovirus infection of the eyes. Am J Epidemiol. 1975 May;101(5):383–390. doi: 10.1093/oxfordjournals.aje.a112106. [DOI] [PubMed] [Google Scholar]
  13. Langford M. P., Georgiades J. A., Stanton G. J., Dianzani F., Johnson H. M. Large-scale production and physicochemical characterization of human immune interferon. Infect Immun. 1979 Oct;26(1):36–41. doi: 10.1128/iai.26.1.36-41.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Langford M. P., Stanton G. J., Barber J. C., Baron S. Early-appearing antiviral activity in human tears during a case of picornavirus epidemic conjunctivitis. J Infect Dis. 1979 Jun;139(6):653–658. doi: 10.1093/infdis/139.6.653. [DOI] [PubMed] [Google Scholar]
  15. Larke R. P. Interferon in the cerebrospinal fluid of children with central nervous system disorders. Can Med Assoc J. 1967 Jan 7;96(1):21–32. [PMC free article] [PubMed] [Google Scholar]
  16. Luby J. P., Stewart W. E., 2nd, Sulkin S. E., Sanford J. P. Interferon in human infections with St. Louis encephalitis virus. Ann Intern Med. 1969 Oct;71(4):703–709. doi: 10.7326/0003-4819-71-4-703. [DOI] [PubMed] [Google Scholar]
  17. MICHAELS R. H., WEINBERGER M. M., HO M. CIRCULATING INTERFERON-LIKE VIRAL INHIBITOR IN PATIENTS WITH MENINGITIS DUE TO HAEMOPHILUS INFLUENZAE. N Engl J Med. 1965 Jun 3;272:1148–1152. doi: 10.1056/NEJM196506032722203. [DOI] [PubMed] [Google Scholar]
  18. McIntosh K. Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr. 1978 Jul;93(1):33–36. doi: 10.1016/s0022-3476(78)80595-2. [DOI] [PubMed] [Google Scholar]
  19. Merigan T. C., Gregory D. F., Petralli J. K. Physical properties of human interferon prepared in vitro and in vivo. Virology. 1966 Aug;29(4):515–522. doi: 10.1016/0042-6822(66)90276-5. [DOI] [PubMed] [Google Scholar]
  20. PETRALLI J. K., MERIGAN T. C., WILBUR J. R. CIRCULATING INTERFERON AFTER MEASLES VACCINATION. N Engl J Med. 1965 Jul 22;273:198–201. doi: 10.1056/NEJM196507222730405. [DOI] [PubMed] [Google Scholar]
  21. Stanton G. J., Langford M. P., Baron S. Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun. 1977 Nov;18(2):370–376. doi: 10.1128/iai.18.2.370-376.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tilles J. G., Finland M. Microassay for human and chick cell interferons. Appl Microbiol. 1968 Nov;16(11):1706–1707. doi: 10.1128/am.16.11.1706-1707.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Trinchieri G., Santoli D., Knowles B. B. Tumour cell lines induce interferon in human lymphocytes. Nature. 1977 Dec 15;270(5638):611–613. doi: 10.1038/270611a0. [DOI] [PubMed] [Google Scholar]
  24. Valle M. J., Bobrove A. M., Strober S., Merigan T. C. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen. J Immunol. 1975 Jan;114(1 Pt 2):435–441. [PubMed] [Google Scholar]
  25. WHEELOCK E. F. INTERFERON IN DERMAL CRUSTS OF HUMAN VACCINIA VIRUS VACCINATIONS POSSIBLE EXPLANATION OF RELATIVE BENIGNITY OF VARIOLATION SMALLPOX. Proc Soc Exp Biol Med. 1964 Dec;117:650–653. doi: 10.3181/00379727-117-29659. [DOI] [PubMed] [Google Scholar]
  26. WHEELOCK E. F., SIBLEY W. A. INTERFERON IN HUMAN SERUM DURING CLINICAL VIRAL INFECTIONS. Lancet. 1964 Aug 22;2(7356):382–385. [PubMed] [Google Scholar]
  27. Weiner L. S., Howell J. T., Langford M. P., Stanton G. J., Baron S., Goldblum R. M., Lord R. A., Goldman A. S. Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis. 1979 Dec;140(6):858–863. doi: 10.1093/infdis/140.6.858. [DOI] [PubMed] [Google Scholar]
  28. Yamaguchi T., Handa K., Shimizu Y., Abo T., Kumagai K. Target cells for interferon production in human leukocytes stimulated by sendai virus. J Immunol. 1977 Jun;118(6):1931–1935. [PubMed] [Google Scholar]
  29. Yin-Murphy M., Lim K. H., Ho Y. M. A coxsackievirus type A24 epidemic of acute conjunctivitis. Southeast Asian J Trop Med Public Health. 1976 Mar;(1):1–5. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES